A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors

NCT05394168 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Henlius Biotech